CENDUCBerkeley

Center for Emerging and Neglected Diseases (CEND) @ UC Berkeley facilitates innovative solutions for infectious disease challenges.

[CENDUCBerkeley @CENDUCBerkeley]

#CalBigGive is TODAY! Donate to support critical programs at CEND focused on student training, public health initiatives, and impactful translational research.

Donate here: https://t.co/1X8OKQk9CC

[CENDUCBerkeley @CENDUCBerkeley]

Paper out on the “Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design.” Go check it out! https://t.co/6jjLng4fCD

[CENDUCBerkeley @CENDUCBerkeley]

Annual CEND Symposium registration NOW OPEN! https://t.co/2XwYgsjMFO
Learn more about circadian rhythms in malaria parasites🦟to improving public health outcomes in low- and middle-income settings 🩺

[CENDUCBerkeley @CENDUCBerkeley]

We'll be hosting an art show by photographer Herlinde Koelbl https://t.co/xzGhDrki0U in Li Ka Shing - you're all invited to the opening reception, Sep 15 at 2pm!

[CENDUCBerkeley @CENDUCBerkeley]

RIP Harald zur Hausen - The Lancet Infectious Diseases https://t.co/4MICwzBQWY

[CENDUCBerkeley @CENDUCBerkeley]

Berkeley SkyDeck's Batch 17 applications JUST OPENED! SkyDeck is an accelerator that offers access to an unparalleled network in Silicon Valley. Those selected will receive $200,000 in investment from the Berkeley SkyDeck Fund. APPLY HERE by Aug 24th: https://t.co/SorYdtvXoi

[CENDUCBerkeley @CENDUCBerkeley]

Happy to share our paper with the @OlzmannLab lab came out today, Congrats all!!
https://t.co/0d6WbTFBvr

[CENDUCBerkeley @CENDUCBerkeley]

#CalBigGive is coming up next Thursday, March 9th. Your donations will allow CEND to continue to help prevent and treat diseases, through student training, public health initiatives and translational research.
Donate here: https://t.co/bnuQPAflS8

[CENDUCBerkeley @CENDUCBerkeley]

Congrats @sanaria_inc and @stephenlhoffman for keeping at it - In Vitro Malaria Sporozoite Production established - a huge leap! https://t.co/hh5dykAVh6

[CENDUCBerkeley @CENDUCBerkeley]

Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better? https://t.co/9mGQ47DWG7

[CENDUCBerkeley @CENDUCBerkeley]

Sleeping sickness: time for dreaming https://t.co/BJ09k7ISbd

[CENDUCBerkeley @CENDUCBerkeley]

Our paper is out today - discovery of approved compounds synergistic with remdesivir! https://t.co/Fjibl1g9As Great collaboration with the Stanley lab, funded by fastgrants et al @berkeleyMCB @SKonermann @ScottBiering

[CENDUCBerkeley @CENDUCBerkeley]

Congratulations L&S alumnae!! https://t.co/Ak8Sa1RiKl

[CENDUCBerkeley @CENDUCBerkeley]

Great job @Fogarty_NIH @NCDCGeorgia for doing low dose Tb treatment trial improving patients' lives. This kind of trial has no financial incentive and is almost never done -https://t.co/mmDkfHm95N

[Rapé Lab @RapeLab]

First retreat in Molecular Therapeutics @berkeleyMCB. What an amazing group of stellar scientists bridging so many disciplines, all excited about turning fundamental mechanism into new modalities! Thank you @BioEnginuityHub @UCBerkeley for hosting us!

[Org. for Women in Science for the Developing World @OwsdSecretariat]

The Call for Applications for the 2023 OWSD-@ElsFoundation Awards for early career women scientists in the developing world is NOW OPEN! This year's awards are in Food security, Agricultural productivity and Sustainable food production. All details at https://t.co/b2EyOoEIkA

[CENDUCBerkeley @CENDUCBerkeley]

Hurry -Deadline July 29 - ASTHM Shope fellowship 25k for arbovirus work https://t.co/upODlBo3Ic

[CENDUCBerkeley @CENDUCBerkeley]

Known to be toxic for a century, lead still poisons thousands of Midwestern kids https://t.co/qDI41jZqf7

[CENDUCBerkeley @CENDUCBerkeley]

Being heard on all-oral therapy for resistant tuberculosis https://t.co/i36XFNqo1T

[CENDUCBerkeley @CENDUCBerkeley]

‘You get goosebumps from the data’: hopes rise for new malaria vaccine https://t.co/NjsE4iQf8L